News

Pharmaceutical Technology on MSN1d
FDA approves Neurelis’ nasal spray for seizures
"FDA approves Neurelis’ nasal spray for seizures" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has b ...
The experts recommend 24-hour or “second-generation” antihistamines like cetirizine (Zyrtec) or fexofenadine (Allegra), which ...
In this younger patient population, diazepam nasal spray was readily absorbed and demonstrated a consistent PK profile with that of older children and adults aged 6 to 59 years.
As compared to controls, elevated nasal levels of ACE2 and TMPRSS2 were associated with a 3.6-fold increased risk of SARS-CoV ...
Experts have also recommended antihistamine eye drops, like Alaway’s, to SELF before. They work immediately and can give your ...
Promising review: "Amazing! When my allergies get me feeling bogged down, I take this and feel relief within minutes. Even ...
This condition occurs when the nasal passages become dependent on the spray to remain open, leading to a vicious cycle of usage and worsening symptoms. Frequent and prolonged use of decongestants can ...
The nasal bones are two wedged-shaped bones that make up the bridge of your nose. They come together at a rigid fibrous joint, forming the thickest part of the nose. Trauma to the face often involves ...
(RTTNews) - Milestone Pharmaceuticals (MIST) announced the FDA issued a Complete Response Letter regarding its New Drug Application for CARDAMYST nasal spray, a prescription medication in ...
Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has been a challenge for Milestone Pharmaceutical in its 22 years. Now the wait will ...
The Food and Drug Administration has turned away a proposed nasal spray from Milestone Pharmaceuticals to treat a type of irregular heartbeat over concerns about how the drug is manufactured.